Retatrutide, by Soma Chems , is attracting increasing attention as a potential therapy for obesity regulation. This unique compound integrates the properties of a GLP-1 receptor stimulant and a GIP receptor stimulant, designed to simply promote reduced body fat but also address related metabolic